Adenylyl cyclase type 6 (AC6) has favorable effects on the failing heart. However, AC6 has two shortcomings that, if resolved, would provide an optimal therapeutic transgene. First, AC6's large size prevents its expression in adeno-associated virus (AAV) vectors, which would enable longer-term expression. Second, AC6's propensity to increase intracellular levels of cAMP is a potential impediment. Recent data from our laboratory indicate that the beneficial effects of AC6, in large measure, are independent of cAMP generation. The elimination of the amino terminus and the two transmembrane domains (M1 &M2) of AC and subsequent fusing the two cytoplasmic domains (C1 &C2) with an 8 amino acid linker yields a C1C2 protein. C1C2 has an intact catalytic domain, but is disengaged from membrane-associated ?-adrenergic receptors (?AR), and therefore less responsive to ?AR stimulation. Our preliminary data indicate that increased expression of C1C2 in cardiac myocytes mimics the beneficial effects of AC6 on Akt activation and ATF3 expression, has favorable effects on cell survival, and improved function of the failing heart. Moreover, C1C2 is sufficiently small to be inserted in an AAV vector with a regulated expression cassette, and will be better suited for targeting to specific microdomains owing to its smaller size. Hypothesis C1C2 expression - independently ?-adrenergic receptor stimulation - will have beneficial effects on the failing heart. The following 5 Aims will examine the mechanism of action and effects of C1C2 on heart function.
Aim 1 To determine the mechanisms by which C1C2 has beneficial effects on cardiac myocytes.
Aim2 To determine if cardiac-directed expression of the optimal C1C2 construct will have favorable effects on normal heart function and have minimal deleterious effects even after prolonged high-level cardiac expression.
Aim 3 To determine if cardiac-directed expression of C1C2 will improve function of the failing heart.
Aim 4 To determine whether cardiac gene transfer of an AAV vector enabling regulated expression of an optimal C1C2 can safely improve function of the failing mouse heart.
Aim 5 To determine whether cardiac gene transfer of an AAV vector enabling regulated expression of an optimal C1C2 can safely improve function of the failing pig heart, perform biodistribution and toxicology studies, and file an IND for initiation of a clinical trial.

Public Health Relevance

This Project focuses upon the discovery and potential use of new therapeutic genes for the treatment of clinical congestive heart failure so its relevance to the mission of the NHLBI and NIH is clear.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL066941-12
Application #
8743233
Study Section
Heart, Lung, and Blood Program Project Review Committee (HLBP)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
12
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Veterans Medical Research Fdn/San Diego
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92161
Suarez, Jorge; Cividini, Federico; Scott, Brian T et al. (2018) Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function. J Biol Chem 293:8182-8195
Schilling, Jan M; Head, Brian P; Patel, Hemal H (2018) Caveolins as Regulators of Stress Adaptation. Mol Pharmacol 93:277-285
Giamouridis, Dimosthenis; Gao, Mei Hua; Lai, N Chin et al. (2018) Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal. JACC Basic Transl Sci 3:249-264
Hastings, Randolph H; Montgrain, Philippe R; Quintana, Rick A et al. (2017) Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression. J Cancer Res Clin Oncol 143:1395-1407
Gao, Mei Hua; Lai, N Chin; Giamouridis, Dimosthenis et al. (2017) Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained ?-adrenergic stimulation. PLoS One 12:e0181282
Penny, William F; Hammond, H Kirk (2017) Randomized Clinical Trials of Gene Transfer for Heart Failure with Reduced Ejection Fraction. Hum Gene Ther 28:378-384
Egawa, Junji; Schilling, Jan M; Cui, Weihua et al. (2017) Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma. FASEB J 31:3403-3411
Breen, Ellen C; Scadeng, Miriam; Lai, N Chin et al. (2017) Functional magnetic resonance imaging for in vivo quantification of pulmonary hypertension in the Sugen 5416/hypoxia mouse. Exp Physiol 102:347-353
Hammond, H Kirk; Penny, William F; Traverse, Jay H et al. (2016) Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial. JAMA Cardiol 1:163-71
Schilling, Jan M; Patel, Hemal H (2016) Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age. J Physiol 594:4581-9

Showing the most recent 10 out of 107 publications